From Breakthrough to Blockbuster Audiolibro Por Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos arte de portada

From Breakthrough to Blockbuster

The Business of Biotechnology

 Vista previa
OFERTA POR TIEMPO LIMITADO

3 meses gratis
Prueba por $0.00
La oferta termina el 31 de julio, 2025 a las 11:59PM PT.
Elige 1 audiolibro al mes de nuestra colección inigualable.
Escucha todo lo que quieras de entre miles de audiolibros, Originals y podcasts incluidos.
Accede a ofertas y descuentos exclusivos.
Premium Plus se renueva automáticamente por $14.95/mes después de 3 meses. Cancela en cualquier momento.

From Breakthrough to Blockbuster

De: Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos
Narrado por: Chris Andrew Ciulla
Prueba por $0.00

$0.00/mes despues de 3 meses. La oferta termina el 31 de julio, 2025 a las 11:59PM PT. Cancela en cualquier momento.

Compra ahora por $17.19

Compra ahora por $17.19

Confirma la compra
la tarjeta con terminación
Cambiar método de pago
Al confirmar tu compra, aceptas las Condiciones de Uso de Audible y el Aviso de Privacidad de Amazon. Impuestos a cobrar según aplique.
Cancelar

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources.

Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs.

From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.

©2022 Oxford University Press (P)2022 Ascent Audio Biotecnología Ciencia Ciencias Biológicas Espíritu Emprendedor Industria de la Medicina y Salud Pequeñas Empresas y Espíritu Emprendedor
Todas las estrellas
Más relevante  
Fantastic book describing the biotech industry from its beginning to now. Engaging and recommended to read or listen.

Excellent description of the biotech industry

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
Nice introduction to the world of pharma R&D, but those who’ve been in the business have probably heard the stories many times already.

Nothing to learn for pharma professionals

Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.